Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Back surgery pain relief: new study tests safer option

NCT ID NCT06513208

First seen Jan 05, 2026 · Last updated May 21, 2026 · Updated 22 times

Summary

This study tests whether giving the anti-inflammatory drug ketorolac after spinal fusion surgery can lower the need for strong opioid painkillers. About 140 adults having one- or two-level lumbar fusion will receive either ketorolac or a placebo for the first 48 hours after surgery. Researchers will also check if ketorolac affects bone healing at 6 and 12 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUMBAR SPINAL FUSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Maryland St. Joseph Medical Center

    RECRUITING

    Towson, Maryland, 21204, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.